Literature DB >> 19632997

Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.

Andrey S Dobroff1, Hua Wang, Vladislava O Melnikova, Gabriel J Villares, Maya Zigler, Li Huang, Menashe Bar-Eli.   

Abstract

Metastatic progression of melanoma is associated with overexpression and activity of cAMP-response element-binding protein (CREB). However, the mechanism by which CREB contributes to tumor progression and metastasis remains unclear. Here, we demonstrate that stably silencing CREB expression in two human metastatic melanoma cell lines, A375SM and C8161-c9, suppresses tumor growth and experimental metastasis. Analysis of cDNA microarrays revealed that CREB silencing leads to increased expression of cysteine-rich protein 61 (CCN1/CYR61) known to mediate adhesion, chemostasis, survival, and angiogenesis. Promoter analysis and chromatin immunoprecipitation assays demonstrated that CREB acts as a negative regulator of CCN1/CYR61 transcription by directly binding to its promoter. Re-expression of CREB in CREB-silenced cells rescued the low CCN1/CYR61 expression phenotype. CCN1/CYR61 overexpression resulted in reduced tumor growth and metastasis and inhibited the activity of matrix metalloproteinase-2. Furthermore, its overexpression decreased melanoma cell motility and invasion through Matrigel, which was abrogated by silencing CCN1/CYR61 in low metastatic melanoma cells. Moreover, a significant decrease in angiogenesis as well as an increase in apoptosis was seen in tumors overexpressing CCN1/CYR61. Our results demonstrate that CREB promotes melanoma growth and metastasis by down-regulating CCN1/CYR61 expression, which acts as a suppressor of melanoma cell motility, invasion and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632997      PMCID: PMC2758018          DOI: 10.1074/jbc.M109.019836

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  The CCN family of genes: a brief history.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

Review 2.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

Authors:  A J Shaywitz; M E Greenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 3.  Transcriptional regulation by the phosphorylation-dependent factor CREB.

Authors:  B Mayr; M Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

4.  Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.

Authors:  D Jean; M Bar-Eli
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.

Authors:  D Sampath; Y Zhu; R C Winneker; Z Zhang
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

6.  Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.

Authors:  J E Gershenwald; W Sumner; T Calderone; Z Wang; S Huang; M Bar-Eli
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

7.  Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways.

Authors:  I Tamura; J Rosenbloom; E Macarak; B Chaqour
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

8.  Functional domains of CCN1 (Cyr61) regulate breast cancer progression.

Authors:  James O'Kelly; Alice Chung; Nathan Lemp; Katya Chumakova; Dong Yin; He-Jing Wang; Jonathan Said; Dorina Gui; Carl W Miller; Beth Y Karlan; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2008-07       Impact factor: 5.650

Review 9.  Skin cancer and solar UV radiation.

Authors:  F R de Gruijl
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

10.  Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

Authors:  Gabriel J Villares; Maya Zigler; Hua Wang; Vladislava O Melnikova; Hong Wu; Ran Friedman; Michael C Leslie; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Anil K Sood; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  41 in total

1.  A Bifunctional MAPK/PI3K Antagonist for Inhibition of Tumor Growth and Metastasis.

Authors:  Stefanie Galbán; April A Apfelbaum; Carlos Espinoza; Kevin Heist; Henry Haley; Karan Bedi; Mats Ljungman; Craig J Galbán; Gary D Luker; Marcian Van Dort; Brian D Ross
Journal:  Mol Cancer Ther       Date:  2017-08-03       Impact factor: 6.261

Review 2.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 3.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

Review 4.  CCN1/CYR61: the very model of a modern matricellular protein.

Authors:  Lester F Lau
Journal:  Cell Mol Life Sci       Date:  2011-07-31       Impact factor: 9.261

5.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

6.  Therapeutic destruction of insulin receptor substrates for cancer treatment.

Authors:  Hadas Reuveni; Efrat Flashner-Abramson; Lilach Steiner; Kirill Makedonski; Renduo Song; Alexei Shir; Meenhard Herlyn; Menashe Bar-Eli; Alexander Levitzki
Journal:  Cancer Res       Date:  2013-05-07       Impact factor: 12.701

7.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

8.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

9.  The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Cell Biol       Date:  2010-06-06       Impact factor: 28.824

10.  EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.

Authors:  Carlos I Rodríguez; Edgardo Castro-Pérez; Kirthana Prabhakar; Laura Block; B Jack Longley; Jaclyn A Wisinski; Michelle E Kimple; Vijayasaradhi Setaluri
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.